Mitomule 20 Injection contains Mitomycin 20mg, a potent antineoplastic antibiotic widely used in chemotherapy regimens for the treatment of various solid tumors. It helps in suppressing tumor cell proliferation and is administered under strict oncological supervision as part of combination therapy protocols.
Mitomycin exerts its anticancer effect by alkylating DNA and inhibiting DNA synthesis, leading to the destruction of rapidly dividing cancer cells. Its broad-spectrum antitumor activity makes it a valuable agent in advanced and recurrent malignancies.
For distributors and healthcare suppliers, Mitomule 20 Injection is a critical oncology product, primarily supplied to cancer hospitals, oncology institutes, and tertiary care centers. Scheduled chemotherapy cycles ensure predictable and sustained institutional demand.
Adding Mitomule 20 Injection to your oncology and chemotherapy therapy segment creates strong opportunities in hospital supply chains, specialty oncology pharmacies, export markets, and third-party manufacturing. Its essential therapeutic role, established clinical efficacy, and strong prescriber trust make it a key product in pharmaceutical distribution portfolios.
Common side effects include nausea, vomiting, fatigue, loss of appetite, and bone marrow suppression resulting in anemia, leukopenia, or thrombocytopenia. Serious adverse effects may include kidney toxicity, lung toxicity, severe infections, or bleeding complications.
Mitomule 20 Injection is indicated for the treatment of cancers such as stomach cancer, pancreatic cancer, bladder cancer, breast cancer, and other solid tumors. It is often used as part of combination chemotherapy regimens as directed by an oncologist.
Mitomule 20 Injection should be administered only by trained healthcare professionals in a hospital or oncology setup. Regular monitoring of blood counts, kidney function, and overall clinical status is essential. Patients should inform their doctor about any existing infections, kidney disease, pregnancy, or breastfeeding before treatment.
Store Mitomule 20 Injection in a cool, dry place away from light as per the manufacturer’s instructions. Keep out of reach of children. Do not use the injection if the vial is damaged or beyond the expiry date printed on the label.